LINES
Levamisole-induced necrosis syndrome (LINES) is a complication characterized by necrosis resulting from exposure to levamisole, a medication with immunomodulatory properties. While LINES can occur with levamisole use alone, most reported cases are associated with the use of cocaine adulterated with levamisole as a cutting agent. This syndrome is marked by skin necrosis, often affecting areas such as the ears, face, and extremities, and is thought to result from levamisole's effects on blood vessels and the immune system.
Recent news mentioning LINES
- — EXCLUSIVE: Southwest Airlines weighs Boeing 787 for long-haul international push, sources say
- — Trump Is Reopening the Middle East’s Deadliest Sectarian Fault Lines
- — Opérations «Dark Clark» et «Bogus Bylines» : OpenAI révèle que ChatGPT a été détourné par des propagandistes russes et iraniens
- — XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
- — Rokt Leaders Join Wayne Gretzky and executives from Fanatics, Lowe's, Southwest Airlines and Mastercard to Discuss Leadership, Commerce Media and AI at Advertising Week New York 2026
- — Govra Brings AI Agents to the Front Lines of Government
- — American Airlines extends Starlink Wi-Fi roll-out to entire mainline fleet
- — INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lincoln Educational Services Corp. of Class Action Lawsuit and Upcoming Deadlines - LINC
- — INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Papa John's International, Inc. of Class Action Lawsuit and Upcoming Deadlines - PZZA
- — INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Simply Good Foods Company of Class Action Lawsuit and Upcoming Deadlines - SMPL
- — INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL
- — INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Endava Plc of Class Action Lawsuit and Upcoming Deadlines - DAVA